@article{1e15dc32bd9d47f5bcd080a269543449,
title = "A comparison of two workflows for regulome and transcriptome-based prioritization of genetic variants associated with myocardial mass",
abstract = "A typical task arising from main effect analyses in a Genome Wide Association Study (GWAS) is to identify single nucleotide polymorphisms (SNPs), in linkage disequilibrium with the observed signals, that are likely causal variants and the affected genes. The affected genes may not be those closest to associating SNPs. Functional genomics data from relevant tissues are believed to be helpful in selecting likely causal SNPs and interpreting implicated biological mechanisms, ultimately facilitating prevention and treatment in the case of a disease trait. These data are typically used post GWAS analyses to fine-map the statistically significant signals identified agnostically by testing all SNPs and applying a multiple testing correction. The number of tested SNPs is typically in the millions, so the multiple testing burden is high. Motivated by this, in this study we investigated an alternative workflow, which consists in utilizing the available functional genomics data as a first step to reduce the number of SNPs tested for association. We analyzed GWAS on electrocardiographic QRS duration using these two workflows. The alternative workflow identified more SNPs, including some residing in loci not discovered with the typical workflow. Moreover, the latter are corroborated by other reports on QRS duration. This indicates the potential value of incorporating functional genomics information at the onset in GWAS analyses.",
keywords = "functional genomics, GWAS, left ventricular mass, SNP preselection",
author = "Elisabetta Manduchi and Daiane Hemerich and {van Setten}, Jessica and Vinicius Tragante and Magdalena Harakalova and Jiayi Pei and Williams, {Scott M.} and {van der Harst}, Pim and Asselbergs, {Folkert W.} and Moore, {Jason H.}",
note = "Funding Information: Funding for this study was provided by the National Institutes of Health (NIH) grant LM010098. This study has been conducted using the UK Biobank Resource under Application Number 24711. FWA is supported by UCL Hospitals NIHR Biomedical Research Centre. This study was also partly supported by the Netherlands Cardiovascular Research Initiative ‐ an initiative with support of the Dutch Heart Foundation, CVON: The Netherlands CardioVascular Research Committee, CVON2014‐40 DOSIS (The Netherlands). Funding Information: Funding for this study was provided by the National Institutes of Health (NIH) grant LM010098. This study has been conducted using the UK Biobank Resource under Application Number 24711. FWA is supported by UCL Hospitals NIHR Biomedical Research Centre. This study was also partly supported by the Netherlands Cardiovascular Research Initiative - an initiative with support of the Dutch Heart Foundation, CVON: The Netherlands CardioVascular Research Committee, CVON2014-40 DOSIS (The Netherlands). No new data were generated in this study. The QRS duration summary statistics for the discovery GWAS are available upon request to the authors of (van der Harst et al.,). The replication GWAS data can be obtained from the UK Biobank (www.ukbiobank.ac.uk), upon application. Identifiers for the publicly available ENCODE (www.encodeproject.org), Roadmap Epigenomics (www.roadmapepigenomics.org), and EnhancerAtlas (www.enhanceratlas.org) data used in this study are listed in Table S1. For the H3K27ac data on HCM patients, please refer to (Hemerich et al.,). Publisher Copyright: {\textcopyright} 2019 Wiley Periodicals, Inc.",
year = "2019",
doi = "10.1002/gepi.22215",
language = "English",
volume = "43",
pages = "717--726",
journal = "Genetic Epidemiology",
issn = "0741-0395",
publisher = "Wiley-Liss Inc.",
number = "6",
}